Survey of Ophthalmology
Volume 54, Issue 6 , Pages 643-662, November 2009

Understanding the Importance of IOP Variables in Glaucoma: A Systematic Review

  • Marla B. Sultan, MD, MBA

      Affiliations

    • New York Eye & Ear Infirmary, New York, New York, USA
    • Pfizer Inc, New York, New York, USA
    • Corresponding Author InformationReprint address: Marla B. Sultan, MD, MBA, Global Clinical Head, Ophthalmology, Pfizer Inc, 235 East 42nd Street, 219/8/97, New York, New York 10017.
    • ,
  • Steven L. Mansberger, MD

      Affiliations

    • Devers Eye Institute, Legacy Health System, Portland, Oregon, USA
    • ,
  • Paul P. Lee, MD, JD

      Affiliations

    • Glaucoma Service, Duke University Eye Center, Durham, North Carolina, USA

published online 10 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Sultan is an employee of Pfizer Inc. Dr. Mansberger is a consultant and has received research funds and honoraria from Pfizer, Allergan, and Alcon. He has also received honoraria from Heidelberg Engineering. Dr. Lee is a consultant for Alcon, Allergan, Genentech, and Pfizer, a guest lecturer for Allergan, Merck, and Pfizer, has equity in Merck and Pfizer, has received research support from Pfizer, Allergan, Alcon, and Genentech, and has patents held by Duke University Eye Center. Editorial support, including literature review, revising the paper based on author feedback, and styling the paper for journal submission, was provided by Dr. Diann Glickman of Zola Associates and was funded by Pfizer Inc.

PII: S0039-6257(09)00116-7

doi:10.1016/j.survophthal.2009.05.001

Survey of Ophthalmology
Volume 54, Issue 6 , Pages 643-662, November 2009

Article Tools